The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...

The ability to control gene expression across a wide range is crucial for many fields, including bioengineering, disease ...

Credit: BaLL LunLa / Shutterstock. Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The ...

The global viral vector and plasmid DNA manufacturing market size was calculated at US$ 7.26 billion in 2024 and is projected to reach around US$ 43.04 billion by 2034, expanding at a compound annual ...

Plasmid DNA is an essential part of cell and gene therapy products. It is utilized as a template vector for cell therapy and non-viral gene therapy and as a raw material to produce adeno-associated ...

Artificial Intelligence - two words that spark equal parts excitement and existential dread. But what exactly is AI? Is it the unseen force behind your eerily well-timed online ads? The chatbot ...

School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P.R. China School of Chemical & Material Engineering, Jiangnan University, Wuxi 214122, P.R. China ...